Screening for mutations of the ferritin light and heavy genes in Parkinson's disease patients with hyperechogenicity of the substantia nigra

Neuroscience Letters

Volumn 352, Issue 1, 2003, Pages 53-56

  Felletschin, Bettina ^a   Bauer, Peter ^a   Walter, Uwe ^b   Behnke, Stephanie ^c   Spiegel, Jörg ^c   Csoti, Ilona ^d   Sommer, Ulrike ^e   Zeiler, Björn ^c   Becker, Georg ^c   Riess, Olaf ^a   Berg, Daniela ^a,f  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

^d Gertrudis Parkinson Klinik   (Germany)

^e DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^f UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Ferritin H; Ferritin L; Iron metabolism; Mutation screening; Parkinson's disease; Transcranial ultrasound

Indexed keywords

ADENINE; FERRITIN; GUANINE; IRON;

ADULT; AGED; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOPPLER ECHOGRAPHY; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; GENETIC SCREENING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DENATURATION; SUBSTANTIA NIGRA;

EID: 10744232522     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2003.08.026     Document Type: Article

References (15)

1. Berg D., Becker G., Riederer P., Rieß O. Iron in neurodegenerative disorders. Neurotox. Res. 4:2002;637-653.
2. Berg D., Becker G., Zeiler B., Tucha O., Hofmann E., Preier M., Benz P., Jost W., Reiners K., Lange K.W. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology. 53:1999;1026-1031.
3. Berg D., Roggendorf W., Schröder U., Klein R., Tatschner T., Benz P., Tucha O., Preier M., Lange K.W., Reiners K., Gerlach M., Becker G. Echogenicity of the substantia nigra is related to its iron content and may characterize subjects with increased vulnerability of the nigrostriatal system. Arch. Neurol. 59:2002;999-1005.
4. Berg D., Siefker C., Becker G. Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings. J. Neurol. 248:2001;684-689.
5. Chen R., Langston J.W., Chan P. Screening of ferritin light polypeptide 460-461InsA mutation in Parkinson's disease patients in North America. Neurosci. Lett. 335:2002;144-146.
6. Curtis A.R., Fey C., Morris C.M., Bindoff L.A., Ince P.G., Chinnery P.F., Coulthard A., Jackson M.J., Jackson A.P., McHale D.P., Hay D., Barker W.A., Markham A.F., Bates D., Curtis A., Burn J. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat. Genet. 28:2001;350-354.
7. Dexter D.T., Wells F.R., Agid F., Lees A.J., Jenner P., Marsden C.D. Increased nigral iron content in postmortem parkinsonian brain. Lancet. 2:1987;1219-1220.
8. Double K.L., Gerlach M., Youdim M.B., Riederer P. Impaired iron homeostasis in Parkinson's disease. J. Neural. Transm. Suppl. 60:2000;37-58.
9. Harrison P.M., Arrosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim. Biophys. Acta. 1275:1996;161-203.
10. Osterova-Golts N., Petrucelli L., Hardy J., Lee J.M., Farer M., Wolozin B. The A53T α-synuclein mutation increases iron dependent aggregation and toxicity. J. Neurosci. 20:2000;6048-6054.
11. Ruprecht-Dörfler P., Berg D., Tucha O., Benz P., Meier-Meitinger M., Alders G.L., Lange K.W., Becker G. Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson's disease. NeuroImage. 18:2003;416-422.
12. Sofic E., Riederer P., Heinsen H., Beckmann H., Reynolds G.P., Hebenstreit G., Youdim M.B. Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J. Neural. Transm. 74:1988;199-205.
13. Thompson K., Menzies S., Muckenthaler M., Torti F.M., Wood T., Torti S.V., Hentze M.W., Beard J., Connor J. Mouse brains deficient in H-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress. J. Neurosci. Res. 71:2003;46-63.
14. Vidal R., Delisle M.B., Rascol O., Ghetti B. Hereditary ferritinopathy. J. Neurol. Sci. 207:2003;110-111.
15. Walter U., Wittstock M., Benecke R., Dressler D. Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease. J. Neural. Transm. 109:2002;191-196.